Due to the ongoing conflict, Sudan continues to grapple with mass displacement, disease outbreaks and malnutrition. The health system has been overwhelmed by attacks on health facilities and the scarcity of medical supplies, equipment, health workers and operational funds. The World Health Organization (WHO) is supporting Sudan with cholera treatments (including antibiotics, oral rehydration solution, intravenous fluids and rapid diagnostic tests), in addition to providing direct support to cholera isolation centres. The UK is funding Water, Sanitation and Hygiene (WASH) and health activities in Sudan via the Sudan Humanitarian Fund, UNICEF, and the International Committee of the Red Cross (ICRC). With support from WHO and health partners, the Ministry of Health is coordinating efforts (in areas of the country that are still accessible) to scale up access to clean water and sanitation facilities, as well as ensuring affected and at-risk communities are aware of transmission risks and proper hygiene practices to reduce contamination risks and prevent further spread of the outbreak. We are supporting the Global Outbreak Alert and Response Network (WHO), and will deploy a Senior Epidemiologist to assist with coordination efforts to bolster the national response. We will continue to monitor the situation closely.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4210", "label" : {"_value" : "Biography information for Lord Ahmad of Wimbledon"} } , "answeringMemberPrinted" : {"_value" : "Lord Ahmad of Wimbledon"} , "dateOfAnswer" : {"_value" : "2023-12-06", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-12-06T17:36:05.357Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "208"} , "answeringDeptShortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "answeringDeptSortName" : {"_value" : "Foreign, Commonwealth and Development Office"} , "date" : {"_value" : "2023-11-22", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Cholera"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what assessment they have made of the cholera outbreak reported by the United Nations as affecting 27 localities across seven states with 78 associated deaths, with more than 3 million people estimated to be at risk by the end of the year.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/738", "label" : {"_value" : "Biography information for Lord Alton of Liverpool"} } , "tablingMemberPrinted" : [{"_value" : "Lord Alton of Liverpool"} ], "uin" : "HL498"} , {"_about" : "http://data.parliament.uk/resources/1465616", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1465616/answer", "answerText" : {"_value" : "
NHS England and NHS Improvement collect information from COVID Medicine Delivery Units (CMDUs) on COVID-19 treatments prescribed and administered. This data includes the number of eligible non-hospitalised patients receiving an antiviral or neutralising monoclonal antibody treatment through a CMDU and the number of eligible hospitalised patients treated with an antiviral, neutralising monoclonal antibody, interleukin-6 inhibitor or JAK inhibitor. This information is published on weekly basis in an online only format and excludes treatments administered as part of clinical trials, such as the PANORAMIC or RECOVERY studies.<\/p>
In addition, a number of independent studies are analysing data on outcomes for treated and untreated patients. While NHS England and NHS Improvement continue to work with the research community to understand this observational data and understand the impact of treatments on outcomes, these studies are conducted independently of the NHS and therefore information on potential publication dates is not held.<\/p>
<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4909", "label" : {"_value" : "Biography information for Lord Kamall"} } , "answeringMemberPrinted" : {"_value" : "Lord Kamall"} , "dateOfAnswer" : {"_value" : "2022-06-23", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-06-23T12:47:31.71Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-05-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Coronavirus: Medical Treatments"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what data outcomes are being collected by the COVID-19 Medicines Delivery Unit following the administration of (1) anti-virals, and (2) Sotrovimab, to COVID-positive patients; and when this data will be published.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4286", "label" : {"_value" : "Biography information for Lord Mendelsohn"} } , "tablingMemberPrinted" : [{"_value" : "Lord Mendelsohn"} ], "uin" : "HL498"} , {"_about" : "http://data.parliament.uk/resources/1327209", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1327209/answer", "answerText" : {"_value" : "
The National Institute for Health and Care Excellence\u2019s (NICE) guideline, Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain<\/em>, published in April 2021, recommends a range of pharmacological and non-pharmacological treatment options for pain management. NICE found there was insufficient evidence on mindfulness to recommend it as an option for pain management within this guideline. However, it made recommendations for research on mindfulness to inform future guidance. A copy of NICE\u2019s guideline is attached.<\/p> The National Health Service is also taking a holistic approach to supporting people\u2019s health and wellbeing by expanding its social prescribing services. This enables general practitioners to refer people to community groups and agencies for practical, emotional and social support, for example when managing pain.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Bethell"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/1327209/answer/attachment/1", "fileName" : {"_value" : "NICE Chronic Pain Guidance (1).pdf"}
, "title" : "NICE Guideline"}
, "dateOfAnswer" : {"_value" : "2021-06-21", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2021-06-21T11:10:11.983Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2021-05-24", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Pain"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government how they will ensure that those seeking support for managing pain are offered a choice of options through the NHS including mindfulness-based therapies, to reduce the proportion of treatments that rely on medication and the risk of overprescribing.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4179", "label" : {"_value" : "Biography information for Baroness Healy of Primrose Hill"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Healy of Primrose Hill"}
], "uin" : "HL498"}
, {"_about" : "http://data.parliament.uk/resources/1171527", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1171527/answer", "answerText" : {"_value" : " The law is clear that for care workers, and other workers, time spent travelling between assignments counts as time worked for National Minimum Wage and National Living Wage (NMW) purposes. Furthermore, the Government issued statutory guidance supporting the implementation of the Care Act which specifies; \u201cRemuneration must be at least sufficient to comply with the NMW legislation for hourly pay or equivalent salary. This will include appropriate remuneration for any time spent travelling between appointments.\u201d<\/em><\/p> <\/p> The Government has more than doubled the NMW compliance and enforcement budget to £27.4 million for 2019/20, up from £13.2 million in 2015/16. HMRC utilise those resources to follow up on every worker complaint received and to undertake proactive investigations. Last year (2018/19), HMRC identified over £6 million in minimum wage arrears within the Human Health and Social Work sector, owed to over 27,000 workers. This includes, but is not limited to, arrears relating to travel time.<\/p> <\/p> Workers can call the ACAS helpline for free, confidential advice about their rights and entitlements. If they want to make a complaint through HMRC, they can do so in complete confidence, either via ACAS or using the online complaints form on GOV.UK. HMRC will protect their anonymity throughout the investigation.<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4686", "label" : {"_value" : "Biography information for Lord Duncan of Springbank"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Duncan of Springbank"}
, "dateOfAnswer" : {"_value" : "2020-01-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2020-01-27T14:41:01.077Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "201"}
, "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "date" : {"_value" : "2020-01-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Care Workers: Pay"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government, further to the Written Answer by Lord Henley on 11 April 2019 (HL15230), how many agencies employing careworkers are paying the costs of such workers for their travel between clients; and what steps they take to ensure that care agencies pay staff appropriate renumeration for any time spent travelling between appointments.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/3596", "label" : {"_value" : "Biography information for Baroness Gardner of Parkes"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Gardner of Parkes"}
], "uin" : "HL498"}
, {"_about" : "http://data.parliament.uk/resources/1167230", "AnsweringBody" : [{"_value" : "Department for Business, Energy and Industrial Strategy"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1167230/answer", "answerText" : {"_value" : " My rt. hon. Friend the Secretary of State for Business, Energy and Industrial Strategy has convened a special cross-government taskforce alongside local stakeholders to support employees, local stakeholders and supply chains. The taskforce is considering existing support schemes available and will also monitor local business impacts.<\/p> <\/p> Local partners are able to advise on support available to suppliers affected by Thomas Cook going insolvent.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4686", "label" : {"_value" : "Biography information for Lord Duncan of Springbank"}
}
, "answeringMemberPrinted" : {"_value" : "Lord Duncan of Springbank"}
, "dateOfAnswer" : {"_value" : "2019-11-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2019-11-05T14:36:54.197Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "201"}
, "answeringDeptShortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "answeringDeptSortName" : {"_value" : "Business, Energy and Industrial Strategy"}
, "date" : {"_value" : "2019-10-29", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Thomas Cook: Insolvency"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government what steps they are taking, if any, to protect Thomas Cook's suppliers from the financial impact of that company's collapse.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4197", "label" : {"_value" : "Biography information for Baroness Doocey"}
}
, "tablingMemberPrinted" : [{"_value" : "Baroness Doocey"}
], "uin" : "HL498"}
], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 5, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}